Determination of acetylcholine concentration in cerebrospinal fluid of patients with neurologic diseases

H. Yamada, M. Otsuka, K. Fujimoto, K. Kawashima, M. Yoshida

研究成果: Article

12 引用 (Scopus)

抜粋

Introduction - Acetylcholine (ACh) is a well known neurotransmitter in the central nervous system, but determining its level in cerebrospinal fluid (CSF) is very difficult and the origin of CSF ACh is still unknown. In this study, we attempted to measure CSF ACh by a specific and sensitive radioimmunoassay (RIA) from patients with neurologic diseases. Material and methods - Patients with cerebral infarction (n = 7), Parkinson's disease (n = 6), spinocerebellar degeneration (n = 6), Alzheimer's disease (n = 3), amyotrophic lateral sclerosis (n = 3) and disc herniation with no central nervous involvement (n = 8) participated to determine the CSF ACh levels. Results - Of these 33 patients, the mean ACh level in CSF was 282.2 ± 61.7 fmol/ml (mean ± SE, range 20-1505.8 fmol/ml). The mean ACh level of spinocerebellar degeneration group was lower than others, but not statistically significant. Conclusion - We conclude that an amount of ACh detectable by RIA is certainly present in CSF.

元の言語English
ページ(範囲)76-78
ページ数3
ジャーナルActa Neurologica Scandinavica
93
発行部数1
出版物ステータスPublished - 1996 1 26

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

フィンガープリント Determination of acetylcholine concentration in cerebrospinal fluid of patients with neurologic diseases' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用